ArticleMedComm2025

Venetoclax and Homoharringtonine-Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T-Cell Precursor Acute Lymphoblastic Leukemia.

Xiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.